AI Analysis AI Analysis of LPCN
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

Stronger technical forecast for Lipocine Inc. stock price after Monday trading
(Updated on Nov 17, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy candidate since Nov 17, 2025

The Lipocine Inc. stock price gained 4.53% on the last trading day (Monday, 17th Nov 2025), rising from $2.87 to $3.00. During the last trading day the stock fluctuated 6.83% from a day low at $2.85 to a day high of $3.05. The price has risen in 6 of the last 10 days and is up by 13.21% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 17 thousand more shares were traded than the day before. In total, 40 thousand shares were bought and sold for approximately $118.95 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -6.05% during the next 3 months and, with a 90% probability hold a price between $2.35 and $3.05 at the end of this 3-month period.

LPCN Signals & Forecast

Mostly positive signals in the chart today. The Lipocine Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $2.85 and $2.91. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, November 04, 2025, and so far it has risen 18.58%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Lipocine Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.

Support, Risk & Stop-loss for Lipocine Inc. stock

Lipocine Inc. finds support from accumulated volume at $2.92 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.195 between high and low, or 6.83%. For the last week, the stock has had daily average volatility of 5.67%.

Our recommended stop-loss: $2.89 (-3.80%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 9 days ago.)

Trading Expectations (LPCN) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Lipocine Inc. to open at $2.97, and during the day (based on 14 day Average True Range), to move between $2.92 and $3.08, which gives a possible trading interval of +/-$0.159 (+/-5.43%) up or down from last closing price. If Lipocine Inc. takes out the full calculated possible swing range there will be an estimated 5.43% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.92 (2.67%) than the resistance at $3.11 (3.67%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Lipocine Inc. stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 2.260 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $2.97 ( 1.16%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

LPCN Performance

Trading levels for LPCN

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 3.16 5.32%
R2 3.09 2.85%
R1 3.04 1.32%
Price 3.00
S1 2.89 -3.64%
S2 2.84 -5.17%
S3 2.77 -7.65%

Accumulated Volume Support & Resistance Levels

Level Price
R3 3.35 11.67%
R2 3.20 6.67%
R1 3.11 3.67%
Price 3.00
S1 2.92 -2.67%
S2 2.89 -3.67%
S3 2.81 -6.33%

FAQ

What is the symbol for Lipocine Inc. Stock and on which exchange is it traded?
The symbol for Lipocine Inc. is LPCN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Lipocine Inc. Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

How to buy Lipocine Inc. Stock?
Lipocine Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Lipocine Inc. Stock.

What's the current price of Lipocine Inc. Stock?
As of the end of day on the Nov 17, 2025, the price of an Lipocine Inc. (LPCN) share was $3.00.

What is the 52-week high and low for Lipocine Inc. Stock?
The 52-week high for Lipocine Inc. Stock is $5.50 and the 52-week low is $2.52.

What is the market capitalization of Lipocine Inc. Stock?
As of the Nov 17, 2025, the market capitalization of Lipocine Inc. is 16.257M.

When is the next earnings date for Lipocine Inc.?
The upcoming earnings date for Lipocine Inc. is Mar 12, 2026.
Click to get the best stock tips daily for free!
ABOUT LIPOCINE INC.
Lipocine
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone replacement therapy. The company's pipeline candidates also include LPCN 1144, an oral prodrug of bioident...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE